Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.
Launched by MUSTANG BIO · Dec 8, 2022
Trial Information
Current as of February 05, 2025
Terminated
Keywords
ClinConnect Summary
Non-interventional, multi-center, long-term follow-up study of subjects previously treated with a Mustang Bio CAR-T cell investigational product in a Mustang Bio sponsored clinical study. Subjects who enroll will be monitored for a total of up to 15 years from the time of their last investigational product infusion.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients previously treated with a Mustang Bio CAR-T cell investigational product in a prior Mustang Bio sponsored clinical study.
- • Patient has provided signed and dated informed consent.
- Exclusion Criteria:
- • None. All patients who have received prior treatment with Mustang Bio CAR-T cell investigational product in a Mustang Bio sponsored clinical study are eligible for this long-term follow up (LTFU) study.
Trial Officials
Bruce Dezube, M.D.
Study Director
Mustang Bio
About Mustang Bio
Mustang Bio, a clinical-stage biopharmaceutical company, specializes in the development of innovative gene and cell therapies for the treatment of severe genetic diseases and cancer. Leveraging cutting-edge scientific research and advanced technology, Mustang Bio focuses on creating transformative therapies that harness the power of the immune system and genetically modified cells to address unmet medical needs. With a commitment to rigorous clinical research and collaboration with leading academic institutions, the company aims to bring novel treatment options to patients suffering from debilitating conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Cleveland, Ohio, United States
Rochester, New York, United States
Duarte, California, United States
Boston, Massachusetts, United States
Durham, North Carolina, United States
Cleveland, Ohio, United States
Houston, Texas, United States
Seattle, Washington, United States
Orange, California, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials